The European Medicines Agency backed the use of Novo Nordisk's popular drug Wegovy to help ease heart failure in people with ...
The products are being advertised as more affordable alternatives to blockbuster weight-loss drugs. Here's what doctors think ...
Obesity-focused biotech BioAge Labs said on Wednesday it was seeking a valuation of as much as $587 million in its initial ...
Novo Nordisk A/S's shares have stalled recently, but this looks like a natural digestion of gains from prior years. Click for ...
Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to ...
Prescribed medications like Ozempic and Wegovy can be expensive and hard to find, leading to a rise in popularity of natural ...
In the heavyweight title match between weight loss meds, we have ourselves a victor.In the battle between Novo Nordisk’s ...
The demand for weight loss medications are on the rise, and now, “natural” GLP-1s are being marketed to help you lose weight.
Wegovy, Zepbound and other cutting-edge weight-loss drugs can be tough to get these days. They’re in short supply, and often ...
Lawsuit is part of a nationwide strategy by Novo Nordisk to protect its trademark and profits from its blockbuster GLP-1 ...
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Glucagon-like peptide 1 (GLP-1) receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), ...